Search results
Order by most recent / most popular / relevance
Results: 1-10 of 13
Indian Supreme Court rules Novartis cancer drug change not patentable
- Shook Hardy & Bacon LLP
- -
- India
- -
- April 4 2013
The Supreme Court of India has rejected the patent application filed by Novartis AG for a beta crystalline form of its cancer drug Gleevec, also
UK and India to fund genomics and bioinformatics tech research
- Shook Hardy & Bacon LLP
- -
- India, United Kingdom
- -
- April 4 2013
According to the U.K.'s Biotechnology and Biological Sciences Research Council (BBSRC), up to £10 million has been jointly pledged by the council and
Drug makers complain about slow regulatory approvals in India
- Shook Hardy & Bacon LLP
- -
- Global, India
- -
- February 21 2013
Pharmaceutical companies have reportedly begun shifting their clinical trials out of India, claiming that bureaucrats have been slow to approve them
Drug launch within six months of controller general approval now required in India
- Shook Hardy & Bacon LLP
- -
- India
- -
- January 24 2013
According to a news source, the Drugs Controller General of India (CG) has announced that pharmaceutical companies failing to launch their drugs
Indian drug industry disputes prohibition on brand names
- Shook Hardy & Bacon LLP
- -
- India
- -
- November 1 2012
According to a news source, the Indian Drugs Manufacturing Association is gearing up to challenge action taken by the country’s drug controller to prevent the sale of medicines under brand names as part of an effort to accelerate sales of less-expensive generics
Scientists oppose SCI’s recommended moratorium on biotech crops
- Shook Hardy & Bacon LLP
- -
- India
- -
- November 1 2012
After an expert committee appointed by the Supreme Court of India (SCI) recommended halting field trials of transgenic food crops for 10 years, biotechnologists, agricultural scientists and agribiotech-industry heads reportedly gathered in Bangalore to oppose the recommendations
Indian biotech association signs MOU with U.S.-based association
- Shook Hardy & Bacon LLP
- -
- India, USA
- -
- October 18 2012
The Association of Biotechnology Led Enterprises (ABLE), representing biotechnology interests in India, has reportedly signed a memorandum of understanding (MOU) with the Washington Biotechnology and Biomedical Association (WBBA), Washington state’s life-sciences trade association
India’s guidance for biosimilar drugs draws cautious industry welcome
- Shook Hardy & Bacon LLP
- -
- India
- -
- September 20 2012
According to a news source, industry has given India’s new guidelines for biosimilar drugs, launched August 15, 2012, a “cautious welcome.”
Union Cabinet approves Indian agriculture ministry’s plan to establish ag biotech institute
- Shook Hardy & Bacon LLP
- -
- India
- -
- August 30 2012
The Union Council of Ministers of India (Union Cabinet) has reportedly approved the Agriculture Ministry’s proposal to establish an Indian Institute of Agricultural Biotechnology at Ranchi at a cost of Rs 287.50 crore (US$51.6 million
India may tighten drug marketing code
- Shook Hardy & Bacon LLP
- -
- India
- -
- July 12 2012
According to a news source, India’s Department of Pharmaceuticals will meet with industry associations and the Medical Council of India on July 18, 2012, to consider whether more stringent marketing rules should be imposed on drug manufacturers
Current Search
- Workarea - Healthcare
- Author - Madeleine McDonough
- Author - John D. Garretson
- Jurisdiction - India